PABPN1 and cholangiocarcinoma: And the results from the GEPIA database analysis, focusing on cancers without paired normal tissues in the TIMER database, demonstrated significantly elevated PABPN1 mRNA expression in CHOL (cholangiocellular carcinoma), DLBC (large B-cell lymphoma), PAAD (pancreatic adenocarcinoma), and THYM (thymoma) except TGCT (testicular cancer) (Figure 1B).